Aigen Investment Management LP Takes Position in Azenta, Inc. $AZTA

Key Points

• Aigen Investment Management LP acquired a new stake in Azenta, Inc. by purchasing 9,429 shares, valued at approximately $327,000, during the first quarter.
• Azenta stock recently traded at $32.08, experiencing a 9.8% increase, with a market cap of $1.47 billion and P/E ratio of -13.26.
• Institutional investors own a significant majority of Azenta’s shares, with ownership reported at 99.08%, reflecting strong confidence from large investors.

Aigen Investment Management LP bought a new stake in shares of Azenta, Inc. (NASDAQ:AZTA - Free Report) during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund bought 9,429 shares of the company's stock, valued at approximately $327,000.

Several other institutional investors and hedge funds have also bought and sold shares of the stock. Farther Finance Advisors LLC increased its stake in Azenta by 788.1% in the first quarter. Farther Finance Advisors LLC now owns 968 shares of the company's stock valued at $33,000 after purchasing an additional 859 shares in the last quarter. Quarry LP acquired a new stake in shares of Azenta in the 4th quarter valued at about $110,000. Sterling Capital Management LLC increased its position in Azenta by 39.8% in the 4th quarter. Sterling Capital Management LLC now owns 2,856 shares of the company's stock valued at $143,000 after buying an additional 813 shares in the last quarter. Mitsubishi UFJ Asset Management Co. Ltd. raised its stake in Azenta by 8.9% during the 1st quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 4,842 shares of the company's stock worth $168,000 after buying an additional 396 shares during the period. Finally, Deutsche Bank AG raised its stake in Azenta by 28.5% during the 4th quarter. Deutsche Bank AG now owns 4,199 shares of the company's stock worth $210,000 after buying an additional 931 shares during the period. 99.08% of the stock is owned by institutional investors.

Azenta Price Performance

NASDAQ AZTA traded up $0.53 on Monday, reaching $30.92. 227,523 shares of the company's stock traded hands, compared to its average volume of 774,509. The stock has a market cap of $1.42 billion, a PE ratio of -12.78 and a beta of 1.59. Azenta, Inc. has a 12 month low of $23.91 and a 12 month high of $55.63. The stock has a 50-day simple moving average of $31.31 and a 200 day simple moving average of $33.36.

Azenta (NASDAQ:AZTA - Get Free Report) last posted its quarterly earnings results on Tuesday, August 5th. The company reported $0.19 EPS for the quarter, beating analysts' consensus estimates of $0.13 by $0.06. The company had revenue of $143.94 million during the quarter, compared to analyst estimates of $149.64 million. Azenta had a negative net margin of 18.45% and a positive return on equity of 1.35%. The firm's revenue was up .0% compared to the same quarter last year. During the same period in the prior year, the business posted $0.14 EPS. As a group, analysts anticipate that Azenta, Inc. will post 0.53 EPS for the current year.

Wall Street Analysts Forecast Growth

A number of research analysts have weighed in on AZTA shares. Raymond James Financial raised shares of Azenta from a "market perform" rating to an "outperform" rating and set a $35.00 price objective on the stock in a research note on Wednesday, August 6th. Stephens began coverage on shares of Azenta in a research report on Tuesday, July 22nd. They issued an "equal weight" rating and a $35.00 price target on the stock. Evercore ISI set a $33.00 price target on Azenta and gave the company an "in-line" rating in a research note on Tuesday, August 5th. Finally, Needham & Company LLC lowered their price objective on Azenta from $59.00 to $40.00 and set a "buy" rating for the company in a research note on Wednesday, May 7th. Three investment analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of "Hold" and an average price target of $35.75.

Azenta Profile

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.